Recent Posts

N.J. Jury Finds Novartis Didn't Fail To Warn About Jaw Risk From Aredia, Zometa Bone Drugs
Posted on 7 Oct 2010 by Tom Moylan

NEW BRUNSWICK, N.J. -- A New Jersey state court jury on Oct. 6 found that Novartis Pharmaceuticals Corp. did not fail to provide adequate warning to a cancer patient's doctor that its bone-saving drugs Aredia and Zometa had a risk of osteonecrosis... Read More

N.J. Appeals Court Affirms Pretrial Rulings In State’s First Aredia/Zometa Trial
Posted on 14 Jun 2012 by Tom Moylan

TRENTON, N.J. - (Mealey's) A New Jersey appeals panel on June 13 affirmed several pretrial rulings in the state's first Aredia/Zometa jaw injury trial, including one that direct-to-consumer advertising by defendant Novartis Pharmaceuticals Corp... Read More